pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Circle Pharma Inc

updated 4mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Phase 1: 1
1Phase 1
Phase 1
CID-078
Human Epidermal Growth Factor Receptor 2 Negative Breast…

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view Circle Pharma Inc jobs →

News

  • Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEO
    Eric Cantor, who represented Virginia in the U.S. House of Representatives for 14 years and served as House majority leader from 2011 to 2014, will step up as PhRMA’s next president and CEO on Nov.…
    fiercebiotech · 1d ago
  • Novo notches up to $1.4B pact with Orbis to develop oral macrocycle cardiometabolic drugs
    The multi-drug partnership with Orbis Medicines—which Novo Holdings has backed since the biotech's seed rounds—is focused on cardiometabolic targets, but the technology at the center of the deal co…
    biospace · 15d ago
  • Gilead reaches HIV PrEP agreements; Hong Kong investigates Cloudbreak IPO
    Plus news about VaxThera, Sironax, Circle Pharma, Nutshell Therapeutics, Evopoint and Sensorion. Gilead’s HIV PrEP pact in Latin America: The California drugmaker said it formed an agreement with t…
    endpoints · 16d ago
identifiers
source
globaldata
top tags
NSCLC1Oncology1
mentioned in
3news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?